Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
52.2%
% of XDNA's 23 holdings also in GNOM
28.6%
% of GNOM's 42 holdings also in XDNA
Overlap by Weight
Sector Drift (XDNA minus GNOM)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XDNA |
Weight in GNOM |
Overlap | |
|---|---|---|---|---|
 |
INTELLIA THERAPEUTICS, INC. | 8.7% | 3.9% | 3.9% |
|
CRISPR THERAPEUTICS AG | 15.1% | 3.2% | 3.2% |
|
BEAM THERAPEUTICS, INC. | 13.7% | 2.9% | 2.9% |
|
AGILENT TECHNOLOGIES INC | 2.7% | 3.2% | 2.7% |
|
VERTEX PHARMACEUTICALS INC | 1.5% | 2.0% | 1.5% |
Position Highlights (Non-Overlapping Exposures)
XDNA Overweight Relative to GNOM
|
CRISPR THERAPEUTICS AG | 11.9% |
|
BEAM THERAPEUTICS, INC. | 10.8% |
|
THERMO FISHER SCIENTIFIC INC | 9.5% |
|
PRIME MEDICINE, INC. | 5.9% |
|
EDITAS MEDICINE, INC. | 5.0% |
|
INTELLIA THERAPEUTICS, INC. | 4.8% |
|
CARIBOU BIOSCIENCES, INC. | 4.4% |
|
VERVE THERAPEUTICS, INC. | 3.9% |
|
ABBVIE INC | 3.8% |
|
POSEIDA THERAPEUTICS, INC. | 3.7% |
XDNA Underweight Relative to GNOM
 |
ENI SPA-SPONSORED ADR | -7.7% |
|
ALNYLAM PHARMACEUTICALS INC | -5.4% |
|
AVIDITY BIOSCIENCES INC | -5.3% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -4.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -4.0% |
|
BIO-TECHNE CORPORATION | -3.9% |
|
SAREPTA THERAPEUTICS INC | -3.9% |
|
NATERA INC | -3.8% |
|
MODERNA, INC. | -3.7% |
|
MYRIAD GENETICS INC | -3.6% |